Cheplapharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHEPLAPHARM, and when can generic versions of CHEPLAPHARM drugs launch?
CHEPLAPHARM has thirteen approved drugs.
There are two US patents protecting CHEPLAPHARM drugs.
There are thirty-two patent family members on CHEPLAPHARM drugs in thirty-one countries and twenty-eight supplementary protection certificates in thirteen countries.
Drugs and US Patents for Cheplapharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cheplapharm | DROXIA | hydroxyurea | CAPSULE;ORAL | 016295-003 | Feb 25, 1998 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cheplapharm | ZYPREXA | olanzapine | TABLET;ORAL | 020592-006 | Sep 9, 1997 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cheplapharm | ZYPREXA | olanzapine | INJECTABLE;INTRAMUSCULAR | 021253-001 | Mar 29, 2004 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-004 | Apr 6, 2000 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cheplapharm | VALCYTE | valganciclovir hydrochloride | FOR SOLUTION;ORAL | 022257-001 | Aug 28, 2009 | AB | RX | Yes | Yes | 9,642,911 | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Cheplapharm | VESANOID | tretinoin | CAPSULE;ORAL | 020438-001 | Nov 22, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-005 | Apr 9, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cheplapharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-004 | Apr 6, 2000 | 6,251,895 | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-004 | Apr 6, 2000 | 5,457,895 | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | 5,229,382*PED | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-002 | Apr 6, 2000 | 6,251,895 | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-001 | Apr 6, 2000 | 5,605,897 | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-003 | Apr 6, 2000 | 5,817,656 | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-002 | Apr 6, 2000 | 5,605,897 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHEPLAPHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 150 mg and 500 mg | ➤ Subscribe | 2008-11-10 |
➤ Subscribe | For Oral Solution | 50 mg/mL | ➤ Subscribe | 2011-03-21 |
➤ Subscribe | Tablets | 450 mg | ➤ Subscribe | 2005-12-27 |
International Patents for Cheplapharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2007332640 | ⤷ Sign Up |
Portugal | 2101733 | ⤷ Sign Up |
Poland | 2101733 | ⤷ Sign Up |
Spain | 2391912 | ⤷ Sign Up |
Canada | 2671470 | ⤷ Sign Up |
Taiwan | 200840585 | ⤷ Sign Up |
Croatia | P20121033 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cheplapharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0129748 | 98C0042 | Belgium | ⤷ Sign Up | PRODUCT NAME: ORLISTAT; REGISTRATION NO/DATE: EU/1/98/071/001 19980729 |
1304992 | C300617 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
0694547 | SPC/GB02/027 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425 |
0454436 | SPC/GB96/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: OLANZAPINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT; REGISTERED: UK EU/1/96/022/001 19960927; UK EU/1/96/022/002 19960927; UK EU/1/96/022/003 19960927; UK EU/1/96/022/004 19960927; UK EU/1/96/022/005 19960927; UK EU/1/96/022/006 19960927; UK EU/1/96/022/007 19960927; UK EU/1/96/022/008 19960927; UK EU/1/96/022/009 19960927; UK EU/1/96/022/010 19960927 |
0316704 | 2001C/021 | Belgium | ⤷ Sign Up | PRODUCT NAME: CAPECITABINE, NATL REGISTRATION NO/DATE: EU/1/00/163/001 20010205; FIRST REGISTRATION: CH 54657 19980610 |
0694547 | C300071 | Netherlands | ⤷ Sign Up | PRODUCT NAME: VALGANCICLOVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: RVG 25992 20010920 |
1304992 | 122013000081 | Germany | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.